Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of material impact of COVID-19 pandemic on the Company under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)'.